Organization Overview
Historical Acquisition Tree
Alternative names
Key: Leo Pharma (5) Acquired (4)
Key: Leo Pharma (13) Acquired (80)
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (3 trials)
abatacept (orencia) (2 trials)
abiraterone (zytiga) (4 trials)
acetaminophen (tylenol) (1 trial)
acetylsalicylic acid (aspirin) (4 trials)
acitretin (soriatane) (1 trial)
alefacept (Amevive) (21 trials)
alemtuzumab (campath) (3 trials)
amphotericin b (fungizone) (7 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (6 trials)
atorvastatin (lipitor) (5 trials)
azathioprine (imuran) (3 trials)
basiliximab (simulect) (9 trials)
betamethasone (celestone) (44 trials)
bicalutamide (casodex) (4 trials)
Bismuth Subcitrate Potassium (Pylera) (1 trial)
calcipotriene (dovonex) (52 trials)
capsaicin (qutenza) (8 trials)
conivaptan (vaprisol) (5 trials)
cyclosporine (sandimmune) (10 trials)
diclofenac (voltaren) (2 trials)
dipyridamole (persantine) (1 trial)
dobutamine (dobutrex) (1 trial)
enzalutamide (xtandi) (82 trials)
epoprostenol (veletri) (1 trial)
everolimus (zortress) (5 trials)
fidaxomicin (dificid) (8 trials)
finasteride (Proscar) (1 trial)
fluconazole (diflucan) (5 trials)
flutamide (eulexin) (3 trials)
fluticasone (cutivate) (2 trials)
fusidic acid (cem-102) (2 trials)
gabapentin (neurontin) (8 trials)
glimepiride (amaryl) (2 trials)
guselkumab (tremfya) (1 trial)
ingenol mebutate (picato) (57 trials)
interferon alpha-2b (Intron-A) (1 trial)
leuprolide (lupron) (14 trials)
levofloxacin (levaquin) (1 trial)
lidocaine (xylocaine) (1 trial)
methylprednisolone (medrol) (12 trials)
micafungin (mycamine) (36 trials)
mirabegron (myrbetriq) (72 trials)
mycophenolate (myfortic) (41 trials)
nicardipine (cardene) (1 trial)
oxybutynin (ditropan) (4 trials)
oxycodone (oxycontin) (1 trial)
palonosetron (aloxi) (1 trial)
pantoprazole (protonix) (1 trial)
pimecrolimus (elidel) (5 trials)
posaconazole (noxafil) (1 trial)
prednisone (meticorten) (34 trials)
pregabalin (lyrica) (3 trials)
propiverine hydrochloride (1 trial)
regadenoson (lexiscan) (36 trials)
ribavirin (virazole) (1 trial)
risperidone (risperdal) (2 trials)
rituximab (rituxan) (5 trials)
rivaroxaban (xarelto) (1 trial)
sirolimus (rapamune) (7 trials)
solifenacin (vesicare) (74 trials)
tacrolimus (prograf) (166 trials)
tamsulosin (flomax) (25 trials)
tinzaparin (Innohep) (18 trials)
tocilizumab (actemra) (2 trials)
tolterodine (detrol) (9 trials)
triamcinolone (kenalog) (1 trial)
vancomycin (Vancocin) (4 trials)
Key: Leo Pharma (13) Acquired (91)
adenosine (Adenocard) (6 trials)
allopurinol (zyloprim) (1 trial)
azacitidine (vidaza) (2 trials)
capecitabine (xeloda) (3 trials)
carboplatin (paraplatin) (7 trials)
celecoxib (celebrex) (3 trials)
certolizumab pegol (cimzia) (4 trials)
cisplatin (platinol) (8 trials)
cyclophosphamide (cytoxan) (2 trials)
cytarabine (cytosar-u) (7 trials)
daclizumab (Zenapax) (3 trials)
dalteparin (fragmin) (1 trial)
degarelix acetate (firmagon) (2 trials)
deoxycholic acid (kybella) (1 trial)
docetaxel (taxotere) (14 trials)
enfortumab vedotin (Padcev) (14 trials)
enoxaparin (lovenox) (4 trials)
erlotinib (tarceva) (65 trials)
etoposide (vepesid) (2 trials)
fludarabine (fludara) (4 trials)
fluorouracil (efudex) (7 trials)
gemcitabine (gemzar) (12 trials)
goserelin (zoladex) (3 trials)
granisetron (kytril) (1 trial)
hydroxychloroquine (plaquenil) (1 trial)
immune globulin (human) (2 trials)
insulin human (humulin) (1 trial)
interferon alfacon-1 (Infergen) (1 trial)
isavuconazonium (cresemba) (32 trials)
itraconazole (sporanox) (5 trials)
midostaurin (rydapt) (2 trials)
mitoxantrone (novantrone) (2 trials)
nateglinide (starlix) (2 trials)
ondansetron (zofran) (1 trial)
oxaliplatin (eloxatin) (7 trials)
paclitaxel (taxol) (13 trials)
pembrolizumab (keytruda) (8 trials)
pioglitazone (actos) (3 trials)
quetiapine (seroquel) (11 trials)
radium-223 (xofigo) (2 trials)
sargramostim (leukine) (3 trials)
sevelamer (renagel) (2 trials)
sitagliptin (januvia) (13 trials)
sulindac (clinoril) (6 trials)
talazoparib (talzenna) (2 trials)
ustekinumab (stelara) (1 trial)
vernakalant hydrochloride (5 trials)
Key: Leo Pharma (18) Acquired (115)
alteplase (Activase) (1 trial)
antithrombin iii (human) (thrombate iii) (1 trial)
atezolizumab (tecentriq) (2 trials)
atrial natriuretic peptide (1 trial)
autologous skeletal myoblast (1 trial)
bevacizumab (avastin) (4 trials)
bortezomib (velcade) (2 trials)
brexpiprazole (rexulti) (1 trial)
cinacalcet (sensipar) (1 trial)
cromoglicic acid (Intal) (2 trials)
deferasirox (exjade) (1 trial)
dutasteride (avodart) (1 trial)
epirubicin (ellence) (1 trial)
exemestane (aromasin) (3 trials)
gadofosveset trisodium (ablavar) (1 trial)
ganciclovir (cytovene) (1 trial)
human embryonic stem cell derived retinal pigmented epithelial cells (2 trials)
hydrocortisone (solu-cortef) (2 trials)
irinotecan (Camptosar) (2 trials)
Isatuximab (Sarclisa) (1 trial)
linagliptin (tradjenta) (1 trial)
liposomal lurtotecan (2 trials)
malononitrilamide-715 (4 trials)
meningococcal a&c vaccine (1 trial)
methyl aminolevulinate (metvixia) (1 trial)
mometasone (elocon) (2 trials)
mupirocin (bactroban) (1 trial)
naproxen (naprosyn) (3 trials)
paliperidone (invega) (1 trial)
panitumumab (vectibix) (1 trial)
pazopanib (votrient) (1 trial)
pemetrexed (alimta) (2 trials)
phosphate-buffered saline (1 trial)
pneumococcal 13-valent conjugate vaccine (prevnar 13) (2 trials)
polyethylene glycol 3350 (colyte) (1 trial)
ranibizumab (lucentis) (1 trial)
sepantronium bromide (10 trials)
sorafenib (nexavar) (4 trials)
sulfamethoxazole (gantanol) (1 trial)
technetium tc-99m sestamibi (2 trials)
technetium tc-99m tetrofosmin kit (1 trial)
tivozanib (Fotivda) (2 trials)
topotecan (hycamtin) (1 trial)
trastuzumab (herceptin) (1 trial)
valaciclovir (Valtrex) (3 trials)
valganciclovir (valcyte) (1 trial)
Key: Leo Pharma (13) Acquired (89)
bupropion (wellbutrin) (1 trial)
cabazitaxel (jevtana kit) (1 trial)
cemiplimab (libtayo) (1 trial)
clopidogrel (plavix) (1 trial)
crizotinib (xalkori) (1 trial)
desipramine (pertofrane) (1 trial)
dextromethorphan (delsym) (2 trials)
ethinyl estradiol (Estinyl) (1 trial)
fluocinolone acetonide (synalar) (1 trial)
gemfibrozil (lopid) (2 trials)
ketoconazole (nizoral) (3 trials)
methadone (methadose) (1 trial)
moxifloxacin (avelox) (4 trials)
omeprazole (prilosec) (3 trials)
petrolatum, white (Vaseline) (3 trials)
pilocarpine (ocusert) (2 trials)
prodrug isavuconazonium sulfate (1 trial)
propranolol (inderal) (1 trial)
repaglinide (prandin) (2 trials)
rimabotulinumtoxinB (Myobloc) (1 trial)
rosuvastatin (crestor) (3 trials)
telavancin (vibativ) (1 trial)
Key: Leo Pharma (1) Acquired (19)
gadoversetamide (optimark) (1 trial)
glucagon-like peptide-1 (1 trial)
hydrochlorothiazide (esidrix) (1 trial)
Acne Vulgaris (Phase 2)
Acute Chest Syndrome (Phase 3)
Acute Lung Injury (Phase 3)
Alopecia (Phase 2)
Alopecia Areata (Phase 2)
Atrophy (Phase 1)
Birth Weight (Phase 4)
Body Weight (Phase 4)
Carcinoma (Phase 3)
Carcinoma, Basal Cell (Phase 2)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma, Squamous Cell (Phase 3)
Condylomata Acuminata (Phase 2)
Connective Tissue Diseases (Phase 2)
Dermatitis (Phase 4)
Dermatitis, Atopic (Phase 4)
Dermatitis, Contact (Phase 4)
Dermatitis, Occupational (Phase 4)
Dermatitis, Phototoxic (Phase 1)
Disseminated Intravascular Coagulation (Phase 2)
Eczema (Phase 4)
Embolism (Phase 4)
Fetal Growth Retardation (Phase 4)
Hyperparathyroidism (Phase 1)
Hyperparathyroidism, Secondary (Phase 1)
Impetigo (Phase 4)
Inflammation (Phase 4)
Insulin Resistance (Phase 4)
Keratosis (Phase 4)
Keratosis, Actinic (Phase 4)
Kidney Failure, Chronic (Phase 4)
Liver Neoplasms (Phase 3)
Lung Injury (Phase 3)
Lupus Erythematosus, Discoid (Phase 2)
Lupus Erythematosus, Systemic (Phase 2)
Lymphoma (Phase 2)
Mastocytosis (Phase 2)
Molluscum Contagiosum (Phase 1)
Multiple Myeloma (Phase 2)
Neoplasm Metastasis (Phase 1)
Neoplasms, Plasma Cell (Phase 2)
Prurigo (Phase 2)
Pruritus (Phase 2)
Psoriasis (Phase 4)
Pulmonary Embolism (Phase 4)
Renal Insufficiency (Phase 4)
Respiratory Distress Syndrome (Phase 3)
Respiratory Distress Syndrome, Newborn (Phase 3)
Sepsis (Phase 2)
Syndrome (Phase 3)
Thromboembolism (Phase 4)
Thrombosis (Phase 4)
Venous Thromboembolism (Phase 4)
Venous Thrombosis (Phase 4)
Warts (Phase 2)